为全球免疫决策制定传播建模指导:一项定性需求评估
研究通过定性访谈评估全球免疫决策者对传播模型证据的使用需求,以支持世界卫生组织制定建模指导。访谈覆盖六个区域不同收入国家的决策者与建模者,发现建模经验丰富者系统使用模型,而经验较少者信心不足;所有参与者均认为需加强能力建设与本地化应用。
要点
- 建模经验丰富者系统使用模型,经验较少者信心不足甚至不使用。
- 决策者希望获得更多信息以理解建模在其情境中的价值。
- 所有参与者均认为需加强能力建设与本地化应用以增强信心。
核心结论
- 研究识别了建模经验丰富与经验不足使用者的不同需求,世界卫生组织正将见解整合入指导制定,以回应免疫决策者的信息需求。
研究设计与样本
- 对来自世界卫生组织六个区域、覆盖低中高收入国家的疫苗接种决策者与建模者进行十五次深度访谈,采用框架法分析转录文本。
主要发现
- 具备建模专长的参与者 firsthand、系统性地使用模型,且常以咨询身份使用。
- 经验较少的用户常承担政策咨询角色,对建模理解信心较低,部分完全不使用。
- 建模经验很少或没有的决策者表示需要更多信息以帮助理解建模在其情境中的价值,许多人支持其潜力。
- 所有参与者均认为需要能力加强和本地化应用以建立使用模型证据的信心。
- 经验较少者表示需要与知识经纪人持续互动参与及培训。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In recent years, mathematical transmission models have been increasingly used to support immunization program decisions and to measure the impact and cost-effectiveness of interventions. However, countries face expertise-and resource-related barriers that limit the use and application of modelled evidence to inform decisions. The World Health Organization (WHO) established an Immunization and Vaccines Implementation Research advisory committee subgroup in 2023 to support immunization decision-makers to effectively generate, translate and use such evidence for strategies, policies, and programs. This study supports this effort, detailing the needs of end-users to inform content and format of the guidance. Fifteen in-depth interviews were conducted with vaccination decision-makers and modelers from all six WHO regions and across low-, middle- and high-income countries. Interviews explored: (i) how modelling is understood and used; (ii) the challenges faced when using modelled evidence; (iii) the types of guidance that would be most useful to enhance the use of modelled evidence. Analysis of transcripts was guided by the framework method, which structures the analysis of qualitative data. Participants with modelling expertise used it firsthand, systematically, and often in an advisory capacity. Less experienced users, often in policy advisory roles, were less confident in their understanding of modelling and some did not use it at all. Decision-makers with little or no modelling experience cited a need for more information to help them understand the value of modelling in their context and many supported its potential. All participants saw a need for capacity strengthening and localised application to instil confidence in using modelled evidence. Those with less experience expressed a need for ongoing interactive engagement with knowledge brokers and training. Insights from this study are being integrated into the development of guidance by WHO. By considering the diverse challenges and needs of both experienced and inexperienced users of modelling, the guidance will support immunization strategy and policy by responding specifically to immunization decision-makers information needs.
引用
- Leask J, Christou-Ergos M, Abdi I, et al. Informing the development of transmission modelling guidance for global immunization decision-making: A qualitative needs assessment. Vaccine. 2025. PMID: 39889533. doi:10.1016/j.vaccine.2025.126800
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。